Cellosaurus SNG-M (CVCL_1707)

Cell line name SNG-M
Synonyms SNGM
Accession CVCL_1707
Resource Identification Initiative To cite this cell line use: SNG-M (RRID:CVCL_1707)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: MD Anderson Cell Lines Project.
Microsatellite instability: Instable (MSI-high) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: Protein expression by reverse-phase protein arrays.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Disease Endometrial adenocarcinoma (NCIt: C7359)
Derived from metastatic site: Obturator lymph node.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_S914 ! SNG-P
Sex of cell Female
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; JCRB; PubMed=25877200

Markers:
AmelogeninX
CSF1PO11,12
D13S3178,11 (Cosmic-CLP; PubMed=25877200)
8,10,11 (JCRB)
D16S53910,12 (Cosmic-CLP)
10,11,12 (JCRB; PubMed=25877200)
D18S5112,18,19
D19S43313.2,14,15
D21S1129,30
D2S133819,24,25
D3S135813,14,15
D5S8189,13
D7S82010,12,13 (Cosmic-CLP)
10,11 (JCRB)
10,11,12 (PubMed=25877200)
D8S117911,13
FGA22
Penta D8,11
Penta E11,14
TH016,7
TPOX8,9
vWA17,20 (Cosmic-CLP; PubMed=25877200)
17,18,20 (JCRB)
Web pages http://tcpaportal.org/mclp/
Publications

PubMed=858140
Ishiwata I., Nozawa S., Inoue T., Okumura H.
Development and characterization of established cell lines from primary and metastatic regions of human endometrial adenocarcinoma.
Cancer Res. 37:1777-1785(1977)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W., Ju Z., Ling S., Vellano C.P., Roebuck P., Yu Q., Eterovic A.K., Byers L.A., Davies M.A., Deng W., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

Cross-references
Cell line collections IFO; IFO50313
JCRB; JCRB0179
Cell line databases/resources CCLE; SNGM_ENDOMETRIUM
Cosmic-CLP; 909735
GDSC; 909735
LINCS_LDP; LCL-1503
Biological sample resources BioSample; SAMN03470892
BioSample; SAMN03472782
Chemistry resources ChEMBL-Cells; CHEMBL3308466
ChEMBL-Targets; CHEMBL1075582
Gene expression databases GEO; GSM827242
GEO; GSM887601
GEO; GSM888684
GEO; GSM1670461
Polymorphism and mutation databases Cosmic; 909735
Cosmic; 1152552
Cosmic; 1241347
Cosmic; 2030483